Ropinirole Tablet, Extended Release
Product Images NDC 43547-554

6 FDA label images from Solco Healthcare Us, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ropinirole (NDC 43547-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

0925224a-figure-01 (0925224a Figure 01)

0925224a-figure-01 (0925224a Figure 01)
Chemical structure of ropinirole hydrochloride, illustrating its molecular framework with a bicyclic core and side chain including nitrogen and oxygen atoms, consistent with the active ingredient of ROPINIROLE tablets.*
FDA Label Image

2 mg 30 Tablets (0925224a Figure 02)

2 mg 30 Tablets (0925224a Figure 02)
Ropinirole Extended-Release Tablets 2 mg oral tablets packaging label by Solco Healthcare US, LLC. The label includes the proprietary name ROPINIROLE, strength 2 mg, dosage form extended-release tablets, and a blue and orange design. The package contains 30 tablets with an NDC of 43547-554-03. Additional text includes dispensing instructions, storage conditions, and manufacturer details from Zhejiang Huahai Pharmaceutical Co., Ltd.*
FDA Label Image

4 mg 30 Tablets (0925224a Figure 03)

4 mg 30 Tablets (0925224a Figure 03)
ROpinirole Extended-Release Tablets 4 mg in a carton containing 30 tablets. The label includes dosing and storage instructions, manufacturer Zhejiang Huahai Pharmaceutical Co. Ltd., and distributor Solco Healthcare US, LLC. The packaging features a blue and white design with dosage strength prominently displayed and a barcode on the left.*
FDA Label Image

6 mg 30 Tablets (0925224a Figure 04)

6 mg 30 Tablets (0925224a Figure 04)
Label for ROPINIROLE Extended-Release Tablets, 6 mg strength, oral tablet form. The label indicates prescription use only and includes a package count of 30 tablets. It is manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. and distributed by Solco Healthcare US, LLC. The label also provides storage instructions and a reminder to dispense patient information separately.*
FDA Label Image

8 mg 30 Tablets (0925224a Figure 05)

8 mg 30 Tablets (0925224a Figure 05)
ROPINIROLE Extended-Release Tablets 8 mg oral dosage form in a carton containing 30 tablets. The label displays the brand name prominently, the strength of 8 mg, and indicates it is for prescription use only. It includes storage instructions, manufacturer and distributor information for Solco Healthcare US, LLC, and Zhejiang Huahai Pharmaceutical Co., Ltd.*
FDA Label Image

12 mg 30 Tablets (0925224a Figure 06)

12 mg 30 Tablets (0925224a Figure 06)
The packaging label for ROPINIROLE Extended-Release Tablets, 12 mg strength, oral dosage form. The label includes the proprietary name ROpiNIRole, highlighting extended-release tablets and a quantity of 30 tablets per container. The labeler is Solco Healthcare US, LLC, with manufacturer Zhejiang Huahai Pharmaceutical Co., Ltd. Additional information includes storage instructions, patient information website, NDC number 43547-558-03, and a caution to dispense the patient information separately to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.